Subscriptions to Prescriptions: Lessons from Louisiana’s Effort to Eliminate Hepatitis C

James Flynn, Bethany Lemont and Barton Willage

No 33617, NBER Working Papers from National Bureau of Economic Research, Inc

Abstract: Hepatitis C is a major public health concern due to its high rates of infection and mortality. Recent breakthroughs in pharmaceuticals not only have the potential to cure hepatitis C but could also cause large positive health externalities through reduced transmission. The high cost of these drugs under traditional reimbursement schemes create large obstacles to care, but a recent first-of-its-kind two-part tariff system in Louisiana aims to circumvent these obstacles using a modified subscription model with an exclusive pharmaceutical provider. Under this model, the medication is provided at no marginal cost to the state to cover the state's Medicaid and incarcerated population. This creates an incentive for Louisiana to aggressively test and treat as many patients as possible in order to maximize the benefits of this agreement. Using a number of different data sources, we implement synthetic control and event-study specifications, and find that detection and treatment of hepatitis C increased dramatically, with meaningful reductions in hepatitis C-related mortality and liver transplants after this agreement. Finally, after calculating the Marginal Value of Public Funds of this agreement, we find that the program more than pays for itself.

JEL-codes: H42 I11 I18 L11 (search for similar items in EconPapers)
Date: 2025-03
Note: EH PE
References: Add references at CitEc
Citations:

Downloads: (external link)
http://www.nber.org/papers/w33617.pdf (application/pdf)
Access to the full text is generally limited to series subscribers, however if the top level domain of the client browser is in a developing country or transition economy free access is provided. More information about subscriptions and free access is available at http://www.nber.org/wwphelp.html. Free access is also available to older working papers.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nbr:nberwo:33617

Ordering information: This working paper can be ordered from
http://www.nber.org/papers/w33617
The price is Paper copy available by mail.

Access Statistics for this paper

More papers in NBER Working Papers from National Bureau of Economic Research, Inc National Bureau of Economic Research, 1050 Massachusetts Avenue Cambridge, MA 02138, U.S.A.. Contact information at EDIRC.
Bibliographic data for series maintained by ().